DiPALS: Diaphragm pacing in patients with amyotrophic lateral sclerosis – A randomised controlled trial
(2016)
Journal Article
McDermott, C. J., Bradburn, M. J., Maguire, C., Cooper, C. L., Baird, W. O., Baxter, S. K., Cohen, J., Cantrill, H., Dixon, S., Ackroyd, R., Baudouin, S., Bentley, A., Berrisford, R., Bianchi, S., Bourke, S. C., Darlison, R., Ealing, J., Elliott, M., Fitzgerald, P., Galloway, S., …Shaw, P. J. (2016). DiPALS: Diaphragm pacing in patients with amyotrophic lateral sclerosis – A randomised controlled trial. Health Technology Assessment, 20(45), 1-218. https://doi.org/10.3310/hta20450
Background Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease resulting in death, usually from respiratory failure, within 2–3 years of symptom onset. Non-invasive ventilation (NIV) is a treatment that when given to patients in respir... Read More about DiPALS: Diaphragm pacing in patients with amyotrophic lateral sclerosis – A randomised controlled trial.